Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Index by author

May 01, 2012; Volume 81,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abramkin, Sergey A.

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  2. Acher, F.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  3. Ameling, S.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

B

  1. Bareford, M. Danielle

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
  2. Barrie, Elizabeth S.

    1. You have access
      mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604
  3. Battaglia, G.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  4. Berger, Walter

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  5. Bertrand, H. O.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  6. Bien, S.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  7. Bonner, Lisa A.

    1. You have access
      Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339
  8. Borland, Gillian

    1. You have access
      Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976
  9. Brown, Alastair J. H.

    1. You have access
      Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
      Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
      Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388
  10. Bruno, V.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  11. Bytzek, Anna K.

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

C

  1. Chemel, Benjamin R.

    1. You have access
      Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339
  2. Chen, Xing-Juan

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  3. Cruickshanks, Nichola

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
  4. Curini, M.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

D

  1. de Jong, Steven

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  2. Dent, Paul

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
  3. Dever, Daniel P.

    1. You have access
      The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
      Daniel P. Dever and Lisa A. Opanashuk
      Molecular Pharmacology May 2012, 81 (5) 669-678; DOI: https://doi.org/10.1124/mol.111.077305
  4. de Vries, Elisabeth G. E.

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  5. Dhankher, Persis

    1. You have access
      A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
  6. Di Marco, R.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  7. Du, Xiao-Na

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  8. Dunlop, Julia

    1. You have access
      Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976

F

  1. Fazio, F.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  2. Fisher, Paul B.

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
  3. Fujimoto, Katsumi

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

G

  1. Galanski, Markus

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  2. Gao, Shan

    1. You have access
      Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976
  3. Gill, JasKiran K.

    1. You have access
      A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
  4. Gojo, Johannes

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  5. Goudet, C.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  6. Grant, Steven

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

H

  1. Hamamura, Kengo

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  2. Hamed, Hossein A.

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586
  3. Hammer, E.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  4. Hanada, Yuichi

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  5. Hartinger, Christian G.

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  6. Heffeter, Petra

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  7. Herzog, S.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  8. Holliday, Nicholas D.

    1. You have access
      Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
      Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
      Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388
  9. Hougardy, Brigitte M. T.

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  10. Huang, Dong-Yang

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  11. Hussner, J.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

I

  1. Inoue, Miki

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

J

  1. Jakupec, Michael A.

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  2. Jia, Zhan-Feng

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  3. Jungwirth, Ute

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

K

  1. Kakimoto, Keisuke

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  2. Keppler, Bernhard K.

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  3. Körner, Wilfried

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321
  4. Koyanagi, Satoru

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  5. Kroemer, H. K.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  6. Kusunose, Naoki

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

L

  1. Lionetto, L.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  2. Liu, Bo-Yi

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000

M

  1. Matsunaga, Naoya

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  2. Meersma, Gert J.

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  3. Millar, Neil S.

    1. You have access
      A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
  4. Molinaro, G.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

N

  1. Ngomba, R. T.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  2. Nichols, David E.

    1. You have access
      Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339
  3. Nicoletti, F.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  4. Niessen, J.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  5. Notartomaso, S.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

O

  1. Ohdo, Shigehiro

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  2. Opanashuk, Lisa A.

    1. You have access
      The Aryl Hydrocarbon Receptor Contributes to the Proliferation of Human Medulloblastoma Cells
      Daniel P. Dever and Lisa A. Opanashuk
      Molecular Pharmacology May 2012, 81 (5) 669-678; DOI: https://doi.org/10.1124/mol.111.077305

P

  1. Pin, J. P.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  2. Poklepovic, Andrew

    1. You have access
      Lapatinib and Obatoclax Kill Tumor Cells through Blockade of ERBB1/3/4 and through Inhibition of BCL-xL and MCL-1
      Nichola Cruickshanks, Hossein A. Hamed, M. Danielle Bareford, Andrew Poklepovic, Paul B. Fisher, Steven Grant and Paul Dent
      Molecular Pharmacology May 2012, 81 (5) 748-758; DOI: https://doi.org/10.1124/mol.112.077586

R

  1. Ritter, C. A.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  2. Rosati, O.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765

S

  1. Sadee, Wolfgang

    1. You have access
      mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604
  2. Sanford, Jonathan C.

    1. You have access
      mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604
  3. Sato, Fuyuki

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406
  4. Scarselli, P.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  5. Schaap, Bessel

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  6. Schroeder, H. W. S.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  7. Schwebe, M.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994
  8. Sheppard, Tom D.

    1. You have access
      A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
  9. Sher, Emanuele

    1. You have access
      A Series of α7 Nicotinic Acetylcholine Receptor Allosteric Modulators with Close Chemical Similarity but Diverse Pharmacological Properties
      JasKiran K. Gill, Persis Dhankher, Tom D. Sheppard, Emanuele Sher and Neil S. Millar
      Molecular Pharmacology May 2012, 81 (5) 710-718; DOI: https://doi.org/10.1124/mol.111.076026
  10. Simmaco, M.

    1. You have access
      Cinnabarinic Acid, an Endogenous Metabolite of the Kynurenine Pathway, Activates Type 4 Metabotropic Glutamate Receptors
      F. Fazio, L. Lionetto, G. Molinaro, H. O. Bertrand, F. Acher, R. T. Ngomba, S. Notartomaso, M. Curini, O. Rosati, P. Scarselli, R. Di Marco, G. Battaglia, V. Bruno, M. Simmaco, J. P. Pin, F. Nicoletti and C. Goudet
      Molecular Pharmacology May 2012, 81 (5) 643-656; DOI: https://doi.org/10.1124/mol.111.074765
  11. Smith, Ryan M.

    1. You have access
      mRNA Transcript Diversity Creates New Opportunities for Pharmacological Intervention
      Elizabeth S. Barrie, Ryan M. Smith, Jonathan C. Sanford and Wolfgang Sadee
      Molecular Pharmacology May 2012, 81 (5) 620-630; DOI: https://doi.org/10.1124/mol.111.076604
  12. Steil, L.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

T

  1. Tan, Shinta

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  2. Toi, Ayumi

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

V

  1. van der Zee, Ate G. J.

    1. You have access
      Human Papilloma Virus 16 E6 RNA Interference Enhances Cisplatin and Death Receptor-Mediated Apoptosis in Human Cervical Carcinoma Cells
      Shinta Tan, Brigitte M. T. Hougardy, Gert J. Meersma, Bessel Schaap, Elisabeth G. E. de Vries, Ate G. J. van der Zee and Steven de Jong
      Molecular Pharmacology May 2012, 81 (5) 701-709; DOI: https://doi.org/10.1124/mol.111.076539
  2. Völker, U.

    1. You have access
      Regulation of Interferon-Inducible Proteins by Doxorubicin via Interferon γ-Janus Tyrosine Kinase-Signal Transducer and Activator of Transcription Signaling in Tumor Cells
      J. Hussner, S. Ameling, E. Hammer, S. Herzog, L. Steil, M. Schwebe, J. Niessen, H. W. S. Schroeder, H. K. Kroemer, C. A. Ritter, U. Völker and S. Bien
      Molecular Pharmacology May 2012, 81 (5) 679-688; DOI: https://doi.org/10.1124/mol.111.075994

W

  1. Watson, Sarah-Jane

    1. You have access
      Differential Signaling by Splice Variants of the Human Free Fatty Acid Receptor GPR120
      Sarah-Jane Watson, Alastair J. H. Brown and Nicholas D. Holliday
      Molecular Pharmacology May 2012, 81 (5) 631-642; DOI: https://doi.org/10.1124/mol.111.077388
  2. Watts, Val J.

    1. You have access
      Ligand-Specific Roles for Transmembrane 5 Serine Residues in the Binding and Efficacy of Dopamine D1 Receptor Catechol Agonists
      Benjamin R. Chemel, Lisa A. Bonner, Val J. Watts and David E. Nichols
      Molecular Pharmacology May 2012, 81 (5) 729-738; DOI: https://doi.org/10.1124/mol.111.077339
  3. Wiejak, Jolanta

    1. You have access
      Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976
  4. Windberger, Ursula

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

X

  1. Xanthos, Dimitris N.

    1. You have access
      Anticancer Activity of Methyl-Substituted Oxaliplatin Analogs
      Ute Jungwirth, Dimitris N. Xanthos, Johannes Gojo, Anna K. Bytzek, Wilfried Körner, Petra Heffeter, Sergey A. Abramkin, Michael A. Jakupec, Christian G. Hartinger, Ursula Windberger, Markus Galanski, Bernhard K. Keppler and Walter Berger
      Molecular Pharmacology May 2012, 81 (5) 719-728; DOI: https://doi.org/10.1124/mol.111.077321

Y

  1. Yarwood, Stephen J.

    1. You have access
      Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase-Dependent SOCS-3 Gene Induction Requires c-Jun, Signal Transducer and Activator of Transcription 3, and Specificity Protein 3 Transcription Factors
      Jolanta Wiejak, Julia Dunlop, Shan Gao, Gillian Borland and Stephen J. Yarwood
      Molecular Pharmacology May 2012, 81 (5) 657-668; DOI: https://doi.org/10.1124/mol.111.076976
  2. Yoshiyama, Yuji

    1. You have access
      Time-Dependent Interaction between Differentiated Embryo Chondrocyte-2 and CCAAT/Enhancer-Binding Protein α Underlies the Circadian Expression of CYP2D6 in Serum-Shocked HepG2 Cells
      Naoya Matsunaga, Miki Inoue, Naoki Kusunose, Keisuke Kakimoto, Kengo Hamamura, Yuichi Hanada, Ayumi Toi, Yuji Yoshiyama, Fuyuki Sato, Katsumi Fujimoto, Satoru Koyanagi and Shigehiro Ohdo
      Molecular Pharmacology May 2012, 81 (5) 739-747; DOI: https://doi.org/10.1124/mol.111.076406

Z

  1. Zhang, Guo-Hong

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  2. Zhang, Hai-Lin

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
  3. Zhang, Xuan

    1. You have access
      Agonist-Dependent Potentiation of Vanilloid Receptor Transient Receptor Potential Vanilloid Type 1 Function by Stilbene Derivatives
      Xuan Zhang, Xiao-Na Du, Guo-Hong Zhang, Zhan-Feng Jia, Xing-Juan Chen, Dong-Yang Huang, Bo-Yi Liu and Hai-Lin Zhang
      Molecular Pharmacology May 2012, 81 (5) 689-700; DOI: https://doi.org/10.1124/mol.111.076000
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 81 (5)
Molecular Pharmacology
Vol. 81, Issue 5
1 May 2012
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Characterization of GRD and LCCH3 from Human Louse
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics